Navigation Links
CellHealth Institute is Named 2013 Edison Award Winner

MONTCLAIR, N.J. (PRWEB) May 09, 2013

CellHealth™ Institute was voted a bronze winner for innovation at the Edison Awards. The event, celebrating 26 years of honoring the best in innovation and excellence in the development of new products and services, took place on April 25th event at Navy Pier in Chicago. Dr. Vincent Giampapa, CellHealth Institute’s founder and chief medical officer, joined hundreds of senior executives from some of the world’s most recognized companies to acknowledge the hard work and commitment of all of the 2013 Edison Award winners.

CellHealth Institute, a biotechnology company focused on cellular health that combines products and services with holistic lifestyle education, was awarded for its innovative health and wellness services. Dr. Vincent Giampapa also spoke about personalized cell health and CHI’s new cell health formula, everycell™, at the ‘Meet The Innovators’ Forum.

“We’re delighted that our innovations in cell health are gaining strong support in such illustrious circles,” said Dr. Vincent Giampapa.

“Our judges recognized CellHealth Institute as a true innovator out of the many products in health and wellness,” said Frank Bonafilia, executive director of the Edison Awards.

The ballot of nominees for the Edison Awards™ was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medical.

One of the evening’s many highlights was the presentation of the Edison Achievement Award to Dr. Paul E. Jacobs, chairman and CEO of Qualcomm Incorporated. The award honors innovation leaders and business executives who have made a significant and lasting contribution to innovation throughout their careers.

About CellHealth™ Institute
CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CellHealth Institute Launches New Cell Health Formula
2. CellHealth Institute Launches with Support from Influential Investors
3. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
4. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
5. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
6. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
7. Stem Cell Institute Public Seminar on Adult Stem Cell Therapy in Miami, Florida May 11th, 2013
8. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
9. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
10. California Healthcare Institute Announces Executive Promotion
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... of the year and one of the premier annual events for pharmaceutical manufacturing: ... from 8–11 November 2015, where ISPE hosted the largest number of attendees in ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
Breaking Biology News(10 mins):